DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA

被引：0
|
作者：
Duggirala, H. J. [1 ]
Herz, N. D. [1 ]
Canos, D. A. [1 ]
Sullivan, R. [1 ]
Schaaf, Richard [1 ]
Pinnow, E. [1 ]
Marinac-Dabic, D. [1 ]
机构：
[1] Ctr Devices & Radiol Hlth Food & Drug Adm, Silver Spring, MD 20993 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [1] Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance
    Zink, Richard C.
    Huang Qin
    Zhang Lu-Yong
    Bao Wen-Jun
    CHINESE JOURNAL OF NATURAL MEDICINES, 2013, 11 (03) : 314 - 320
  • [2] Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
    Li, Liangxia
    Xu, Qianqian
    Liu, Yarui
    Pang, Liangfang
    Cui, Zhou
    Lu, Yuanyuan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system
    Huang, Shuohan
    Guo, Zihan
    Wang, Mengmeng
    She, Youjun
    Ye, Xuan
    Zhai, Qing
    Liu, Jiyong
    Du, Qiong
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (02) : 175 - 181
  • [4] A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database
    Carnovale, Carla
    Mazhar, Faizan
    Pozzi, Marco
    Gentili, Marta
    Clementi, Emilio
    Radice, Sonia
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1161 - 1169
  • [5] Data pharmacovigilance analysis of medroxyprogesterone-related adverse events in the FDA adverse event reporting system
    Wang, Xiaomeng
    Wang, Jimei
    Liu, Fang
    Zhang, Kexin
    Zhao, Min
    Xu, Lin
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [6] A disproportionality analysis of FDA adverse event reporting system events for misoprostol
    Yang, Li
    Xu, Wenting
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [7] PHARMACOVIGILANCE ANALYSIS OF FDA ADVERSE EVENTS REPORTING SYSTEM FOR MAVACAMTEN
    Matai, Pallavi
    Amirian, Aslan
    Khadka, Sulochana
    Gavilanes, Diana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 560 - 560
  • [8] Analysis of Reported Adverse Events Related to Hemospray an FDA MAUDE Database Study
    Ali, Hassam
    Dahiya, Dushyant Singh
    Gangwani, Manesh K.
    Patel, Pratik
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (10) : 1070 - 1071
  • [9] Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance database
    Modingam, Pamella
    Faillie, Jean-Luc
    Campillo, Jeremy T.
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (11):
  • [10] A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
    Song, Yongfu
    Wang, Zhuang
    Wang, Na
    Xie, Xiaofei
    Zhu, Tieshi
    Wang, Yongji
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345